Additional information
White powder
1365545-42-1
ACI-043806
(4S,4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-[2,5-bis(trißuoromethyl)phenyl]-4-chloro-4a,6adimethyl-2-oxohexadecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide
(4S,4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-[2,5-bis(trißuoromethyl)phenyl]-4-chloro-4a,6adimethyl-2-oxohexadecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide
275.9-277.9°C
C27H31ClF6N2O2
564.99
cold Condition
-20°C
N-[2,5-Bis(trifluoromethyl)phenyl]-1?-chloro-3-oxo-4-aza-5?-androstane-17?-carboxamide
5-alpha reductase inhibitor





![sec-BUTYL PACLITAXEL (25 mg) ((2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-Bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl (αR,βS)-α-hydroxy-β-[[(2S)-2-methyl-1-oxobutyl]amino]benzenepropanoate)](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)